| Groupings of characteristics that promote higher statin adherence |
| Electronic health record Grouping |
Clinical Interpretation |
Top characteristics |
P-value |
| Factor 1 |
Atrial fibrillation |
AtenololAtrial fibrillation |
<0.001 |
| Sciatica |
| Hypokalemia |
| Infective otitis externa |
| Hytrin |
| Palpitations |
| Ecotrin |
| Muscular strength training |
| Prochlorperazine |
| Factor 3 |
Diabetes/eye disease |
Aspirin |
<0.001 |
| Monlet lancets |
| Vitalet |
| Fundus photography |
| Senile nuclear sclerosis |
| Glynase |
| Accu-Chek |
| Softclix |
| Screening eye conditions |
| Multivitamin |
| Factor 8 |
Congestive heart failure |
Congestive heart failure |
0.0001 |
| Furosemide |
| Lanoxin |
| Potassium chloride |
| Atrial Fibrillation |
| K-Dur |
| Klor-Con M20 |
| Spironolactone |
| Coronary atherosclerosis of unspecified type of vessel |
| Coreg |
| |
| Factor 9 |
Sinus disease and allergies |
Flonase |
0.008 |
| Allergic rhinitis |
| Chronic rhinitis |
| Deep sea |
| Chronic sinusitis |
| Claritin |
| Dysfunction Eustachian tube |
| Serevent discus |
| Allergy, unspecified |
| Allegra |
| |
| Factor 11 |
Lisinopril |
Lisinopril |
0.01 |
| Vitalet |
| Softclix |
| Somatic dysfunction, thoracic |
| Impotence, organic origin |
| Cetaphil |
| Patient education |
| Lateral epicodylitis |
| Theophylline anhydrous |
| Caltrate-600 Plus |
| |
| Factor 13 |
Women’s health maintenance |
Pelvic/clinical breast screen exam |
0.04 |
| Screening-malignant neoplasms cervix |
| Other specified counseling |
| Screen malignant neoplasm-vagina |
| Screening Papanicolaou smear |
| Routine gynecological exam |
| Acquired absence genital organ |
| Screen malignant neoplasm-breast |
| Fecal occult blood test |
| Vaginitis |
| Groupings of characteristics that promote lower statin adherence |
| Factor 2 |
Physical medicine and rehabilitation |
Traction/Mechanical modality |
<0.001 |
| Physical therapy re-evaluation |
| Hot or cold packs therapy |
| Manual therapy service |
| Group therapeutic procedures |
| Ultrasound |
| Therapeutic activities |
| Therapeutic exercise |
| Physical therapy evaluation |
| Electrical stimulation |
| Factor 4 |
Treatment for insomnia, pain |
Ambien |
<0.001 |
| Insomnia |
| Duragesic |
| Morphine sulfate |
| Psychotherapy w/ E/M services |
| Oxycontin |
| Ambien CR |
| Klonopin |
| Seroquel |
| Lumbago |
| Factor 5 |
Eye disease |
Presbyopia |
<0.001 |
| Astigmatism |
| Regular astigmastism |
| Spectacle services |
| Hypermetropia |
| Myopia |
| Refractive state |
| Ophthalmologic services |
| Spectacle Services (Including prosthesis for aphakia) |
| Contact lens evaluation |
| Factor 6 |
Treatment for upper respiratory infection |
Zithromax |
<0.001 |
| Robitussin A-C |
| Guaituss DM |
| Aerochamber |
| Guaituss AC |
| Tessalon perle |
| Acute bronchitis |
| Inhalation treatment for acute airway obstruction |
| Twice-a-day |
| Mucinex |
| Factor 7 |
Treatment for pain; antibiotics |
Hydrocodone w/ acetaminophen |
<0.001 |
| Oxycodone Hcl- acetaminophen |
| Carisoprodol |
| Duragesic |
| Promethazine |
| Tizanadine |
| Lovenox |
| Hyosyamine sulfate |
| Cephalexin |
| Levaquin |
| Factor 10 |
Asthma/ Chronic obstructive pulmonary disease |
Asthma |
0.002 |
| Albuterol sulfate |
| Ipratropium bromide |
| Aerochamber |
| Nebulizer treatment |
| Chronic obstructive pulmonary dis |
| Theophylline anhydrous |
| Advair diskus |
| Albuterol |
| Spiriva |
| Factor 12 |
Musculoskeletal pain |
Mobic |
0.03 |
| Lumbosacral neuritis |
| Lumbar disc displacement |
| Arthropathy |
| Vioxx |
| Joint pain-pelvis |
| Osteoarthrosis |
| Somatic dysfunction lumbar |
| Myalgia and myositis |
| Sciatica |
